![Report New Zealand - Hormones, Prostaglandins, Thromboxanes and Leukotrienes - Market Analysis, Forecast, Size, Trends and Insights for 499$](/landing/img/reports/new-zealand-hormones-prostaglandins-thromboxanes-and-leukotrienes-market-analysis-forecast-size-trends-and-insights.webp)
New Zealand - Hormones, Prostaglandins, Thromboxanes and Leukotrienes - Market Analysis, Forecast, Size, Trends and Insights
Get instant access to more than 2 million reports, dashboards, and datasets on the IndexBox Platform.
View PricingNew Zealand: Market for Hormones, Prostaglandins, Thromboxanes And Leukotrienes 2024
Market Size for Hormones, Prostaglandins, Thromboxanes And Leukotrienes in New Zealand
The New Zealand market for hormones, prostaglandins, thromboxanes and leukotrienes skyrocketed to $X in 2023, with an increase of X% against the previous year. Over the period under review, consumption saw a strong expansion. Over the period under review, the market hit record highs in 2023 and is likely to see gradual growth in years to come.
Production of Hormones, Prostaglandins, Thromboxanes And Leukotrienes in New Zealand
In value terms, hormones, prostaglandins, thromboxanes and leukotrienes production shrank to $X in 2023 estimated in export price. Over the period under review, production, however, showed a modest increase. The most prominent rate of growth was recorded in 2013 when the production volume increased by X% against the previous year. Over the period under review, production hit record highs at $X in 2015; however, from 2016 to 2023, production stood at a somewhat lower figure.
Exports of Hormones, Prostaglandins, Thromboxanes And Leukotrienes
Exports from New Zealand
Hormones, prostaglandins, thromboxanes and leukotrienes exports from New Zealand dropped rapidly to X tons in 2023, waning by X% on 2022. Over the period under review, exports continue to indicate a abrupt contraction. The most prominent rate of growth was recorded in 2013 when exports increased by X% against the previous year. As a result, the exports reached the peak of X tons. From 2014 to 2023, the growth of the exports remained at a lower figure.
In value terms, hormones, prostaglandins, thromboxanes and leukotrienes exports contracted notably to $X in 2023. Overall, exports showed a deep setback. The growth pace was the most rapid in 2013 with an increase of X% against the previous year. Over the period under review, the exports reached the maximum at $X in 2014; however, from 2015 to 2023, the exports stood at a somewhat lower figure.
Exports by Country
Canada (X kg), Uruguay (X kg) and Brazil (X kg) were the main destinations of hormones, prostaglandins, thromboxanes and leukotrienes exports from New Zealand, with a combined X% share of total exports.
From 2012 to 2023, the biggest increases were recorded for Uruguay (with a CAGR of X%), while shipments for the other leaders experienced more modest paces of growth.
In value terms, the largest markets for hormones, prostaglandins, thromboxanes and leukotrienes exported from New Zealand were Belgium ($X), Australia ($X) and Japan ($X), together comprising X% of total exports. Brazil, South Africa, Israel, Canada, Uruguay, Chile and the United States lagged somewhat behind, together accounting for a further X%.
Uruguay, with a CAGR of X%, recorded the highest growth rate of the value of exports, in terms of the main countries of destination over the period under review, while shipments for the other leaders experienced mixed trend patterns.
Export Prices by Country
In 2023, the average export price for hormones, prostaglandins, thromboxanes and leukotrienes amounted to $X,454 per ton, shrinking by X% against the previous year. Overall, export price indicated a tangible increase from 2012 to 2023: its price increased at an average annual rate of X% over the last eleven years. The trend pattern, however, indicated some noticeable fluctuations being recorded throughout the analyzed period. Based on 2023 figures, hormones, prostaglandins, thromboxanes and leukotrienes export price increased by X% against 2017 indices. The most prominent rate of growth was recorded in 2014 when the average export price increased by X%. The export price peaked at $X,566 per ton in 2015; however, from 2016 to 2023, the export prices remained at a lower figure.
There were significant differences in the average prices for the major export markets. In 2023, amid the top suppliers, the country with the highest price was Belgium ($X,478 per ton), while the average price for exports to Uruguay ($X per ton) was amongst the lowest.
From 2012 to 2023, the most notable rate of growth in terms of prices was recorded for supplies to Australia (X%), while the prices for the other major destinations experienced more modest paces of growth.
Imports of Hormones, Prostaglandins, Thromboxanes And Leukotrienes
Imports into New Zealand
In 2023, approx. X kg of hormones, prostaglandins, thromboxanes and leukotrienes were imported into New Zealand; shrinking by X% against the previous year's figure. Over the period under review, imports continue to indicate a noticeable decline. The pace of growth appeared the most rapid in 2017 with an increase of X%. Over the period under review, imports hit record highs at X tons in 2018; however, from 2019 to 2023, imports stood at a somewhat lower figure.
In value terms, hormones, prostaglandins, thromboxanes and leukotrienes imports dropped notably to $X in 2023. In general, imports, however, continue to indicate a relatively flat trend pattern. The growth pace was the most rapid in 2015 when imports increased by X%. Over the period under review, imports hit record highs at $X in 2022, and then declined dramatically in the following year.
Imports by Country
Taiwan (Chinese) (X kg), the United States (X kg) and Australia (X kg) were the main suppliers of hormones, prostaglandins, thromboxanes and leukotrienes imports to New Zealand, with a combined X% share of total imports.
From 2012 to 2023, the biggest increases were recorded for Australia (with a CAGR of X%), while purchases for the other leaders experienced more modest paces of growth.
In value terms, the United States ($X) constituted the largest supplier of hormones, prostaglandins, thromboxanes and leukotrienes to New Zealand, comprising X% of total imports. The second position in the ranking was taken by Australia ($X), with an X% share of total imports. It was followed by China, with a X% share.
From 2012 to 2023, the average annual rate of growth in terms of value from the United States stood at X%. The remaining supplying countries recorded the following average annual rates of imports growth: Australia (X% per year) and China (X% per year).
Import Prices by Country
The average import price for hormones, prostaglandins, thromboxanes and leukotrienes stood at $X per kg in 2023, rising by X% against the previous year. Over the period under review, the import price saw temperate growth. The pace of growth was the most pronounced in 2013 an increase of X%. As a result, import price reached the peak level of $X per kg. From 2014 to 2023, the average import prices remained at a somewhat lower figure.
There were significant differences in the average prices amongst the major supplying countries. In 2023, amid the top importers, the country with the highest price was the United States ($X per kg), while the price for Singapore ($X per kg) was amongst the lowest.
From 2012 to 2023, the most notable rate of growth in terms of prices was attained by India (X%), while the prices for the other major suppliers experienced mixed trend patterns.
Source: IndexBox Platform
This report provides an in-depth analysis of the market for hormones, prostaglandins, thromboxanes and leukotrienes in New Zealand. Within it, you will discover the latest data on market trends and opportunities by country, consumption, production and price developments, as well as the global trade (imports and exports). The forecast exhibits the market prospects through 2030.
Product coverage:
- Prodcom 21105200 - Hormones, prostaglandins, thromboxanes and leukotrienes, n atural or reproduced by synthesis, derivatives and structural analogues thereof, including chain modified polypeptides, u sed primarily as hormones
Country coverage:
- New Zealand
Data coverage:
- Market volume and value
- Per Capita consumption
- Forecast of the market dynamics in the medium term
- Trade (exports and imports) in New Zealand
- Export and import prices
- Market trends, drivers and restraints
- Key market players and their profiles
Reasons to buy this report:
- Take advantage of the latest data
- Find deeper insights into current market developments
- Discover vital success factors affecting the market
This report is designed for manufacturers, distributors, importers, and wholesalers, as well as for investors, consultants and advisors.
In this report, you can find information that helps you to make informed decisions on the following issues:
- How to diversify your business and benefit from new market opportunities
- How to load your idle production capacity
- How to boost your sales on overseas markets
- How to increase your profit margins
- How to make your supply chain more sustainable
- How to reduce your production and supply chain costs
- How to outsource production to other countries
- How to prepare your business for global expansion
While doing this research, we combine the accumulated expertise of our analysts and the capabilities of artificial intelligence. The AI-based platform, developed by our data scientists, constitutes the key working tool for business analysts, empowering them to discover deep insights and ideas from the marketing data.
-
1. INTRODUCTION
Making Data-Driven Decisions to Grow Your Business
- REPORT DESCRIPTION
- RESEARCH METHODOLOGY AND AI PLATFORM
- DATA-DRIVEN DECISIONS FOR YOUR BUSINESS
- GLOSSARY AND SPECIFIC TERMS
-
2. EXECUTIVE SUMMARY
A Quick Overview of Market Performance
- KEY FINDINGS
- MARKET TRENDS This Chapter is Available Only for the Professional Edition PRO
-
3. MARKET OVERVIEW
Understanding the Current State of The Market and Its Prospects
- MARKET SIZE
- MARKET STRUCTURE
- TRADE BALANCE
- PER CAPITA CONSUMPTION
- MARKET FORECAST TO 2030
-
4. MOST PROMISING PRODUCT
Finding New Products to Diversify Your Business
This Chapter is Available Only for the Professional Edition PRO- TOP PRODUCTS TO DIVERSIFY YOUR BUSINESS
- BEST-SELLING PRODUCTS
- MOST CONSUMED PRODUCT
- MOST TRADED PRODUCT
- MOST PROFITABLE PRODUCT FOR EXPORT
-
5. MOST PROMISING SUPPLYING COUNTRIES
Choosing the Best Countries to Establish Your Sustainable Supply Chain
This Chapter is Available Only for the Professional Edition PRO- TOP COUNTRIES TO SOURCE YOUR PRODUCT
- TOP PRODUCING COUNTRIES
- TOP EXPORTING COUNTRIES
- LOW-COST EXPORTING COUNTRIES
-
6. MOST PROMISING OVERSEAS MARKETS
Choosing the Best Countries to Boost Your Exports
This Chapter is Available Only for the Professional Edition PRO- TOP OVERSEAS MARKETS FOR EXPORTING YOUR PRODUCT
- TOP CONSUMING MARKETS
- UNSATURATED MARKETS
- TOP IMPORTING MARKETS
- MOST PROFITABLE MARKETS
7. PRODUCTION
The Latest Trends and Insights into The Industry
- PRODUCTION VOLUME AND VALUE
8. IMPORTS
The Largest Import Supplying Countries
- IMPORTS FROM 2012–2023
- IMPORTS BY COUNTRY
- IMPORT PRICES BY COUNTRY
9. EXPORTS
The Largest Destinations for Exports
- EXPORTS FROM 2012–2023
- EXPORTS BY COUNTRY
- EXPORT PRICES BY COUNTRY
-
10. PROFILES OF MAJOR PRODUCERS
The Largest Producers on The Market and Their Profiles
This Chapter is Available Only for the Professional Edition PRO -
LIST OF TABLES
- Key Findings In 2023
- Market Volume, In Physical Terms, 2012–2023
- Market Value, 2012–2023
- Per Capita Consumption In 2012-2023
- Imports, In Physical Terms, By Country, 2012–2023
- Imports, In Value Terms, By Country, 2012–2023
- Import Prices, By Country Of Origin, 2012–2023
- Exports, In Physical Terms, By Country, 2012–2023
- Exports, In Value Terms, By Country, 2012–2023
- Export Prices, By Country Of Destination, 2012–2023
-
LIST OF FIGURES
- Market Volume, In Physical Terms, 2012–2023
- Market Value, 2012–2023
- Market Structure – Domestic Supply vs. Imports, In Physical Terms, 2012-2023
- Market Structure – Domestic Supply vs. Imports, In Value Terms, 2012-2023
- Trade Balance, In Physical Terms, 2012-2023
- Trade Balance, In Value Terms, 2012-2023
- Per Capita Consumption, 2012-2023
- Market Volume Forecast to 2030
- Market Value Forecast to 2030
- Products: Market Size And Growth, By Type
- Products: Average Per Capita Consumption, By Type
- Products: Exports And Growth, By Type
- Products: Export Prices And Growth, By Type
- Production Volume And Growth
- Exports And Growth
- Export Prices And Growth
- Market Size And Growth
- Per Capita Consumption
- Imports And Growth
- Import Prices
- Production, In Physical Terms, 2012–2023
- Production, In Value Terms, 2012–2023
- Imports, In Physical Terms, 2012–2023
- Imports, In Value Terms, 2012–2023
- Imports, In Physical Terms, By Country, 2023
- Imports, In Physical Terms, By Country, 2012–2023
- Imports, In Value Terms, By Country, 2012–2023
- Import Prices, By Country Of Origin, 2012–2023
- Exports, In Physical Terms, 2012–2023
- Exports, In Value Terms, 2012–2023
- Exports, In Physical Terms, By Country, 2023
- Exports, In Physical Terms, By Country, 2012–2023
- Exports, In Value Terms, By Country, 2012–2023
- Export Prices, By Country Of Destination, 2012–2023
Recommended reports
This report provides an in-depth analysis of the market for hormones, prostaglandins, thromboxanes and leukotrienes in Asia.
This report provides an in-depth analysis of the market for hormones, prostaglandins, thromboxanes and leukotrienes in the U.S..
This report provides an in-depth analysis of the market for hormones, prostaglandins, thromboxanes and leukotrienes in China.
This report provides an in-depth analysis of the market for hormones, prostaglandins, thromboxanes and leukotrienes in the EU.
This report provides an in-depth analysis of the global market for hormones, prostaglandins, thromboxanes and leukotrienes.
- Market Research in New Zealand
- Price for Hormones, Prostaglandins, Thromboxanes and Leukotrienes New Zealand
- Hormones Market
- Sterile Medical Adhesion Barrier Market
- Glycosides and Vegetable Alkaloids Market
- Antibiotic Market
- Organ Extracts Market
- Antisera Market
- Biological Product Market
- Veterinary Medicine Vaccines Market